LinKinVax Puts Together a Highly Experienced Team From the World of Biopharmaceuticals to Lead the Clinical Development and Upscaling of Its Vaccine Platform
Retrieved on:
Thursday, May 19, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Clinical Trials, Chemistry, GSK, MBA, Knowledge, Health, Kellogg-HKUST Executive MBA Program, R, Public health, Toxicology, Functional presence engine, Infection, CSR, Lists of television programs, Vaccine, COVID-19, Quality control, DESS, Pharmacy, Health care, CMC, Hasna Begum, Engineering, CRO, Paris-Sud University, Technology, Biomarker, Ministry of Education (Malaysia), ESSEC, CMO, HIV, Amgen, Cancer, Neutralizing antibody, Innovation, Pharmaceutical industry, Management, Eurofins Scientific, Audencia Business School, Protein structure
We are delighted to welcome these four experts in healthcare product development.
Key Points:
- We are delighted to welcome these four experts in healthcare product development.
- Their sound knowledge and extensive experience of the biopharmaceuticals industry will provide invaluable support for the various clinical stages of our drug candidates.
- She has developed and registered drugs on a global scale and acquired in-depth knowledge of sterile injectables.
- Alexandra holds a doctorate in pharmacy from Paris V University and an Executive MBA in Healthcare Management from IAE Sorbonne Business School.